News for Pacific Biosciences of California, Inc. (PACB)

In recent analyst actions, Bernstein's Eve Burstein has adjusted the firm's price target for PacBio (PACB), reducing it from $2 to $1.50. However, the firm main

U.S. stocks were higher, with the Dow Jones index surging over 300 points on Wednesday. Shares of The Simply Good Foods Company SMPL rose sharply during Wednes...

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.

We recently compiled a list of the 10 Most Volatile Stocks Under $3 For Day Trading. In this article, we are going to take a look at where Pacific Biosciences of California, Inc.

In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript February 13, 2025Pacific Biosciences of California, Inc. beats earnings expectations.

U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday. Shares of The Goodyear Tire & Rubber Company GT rose sharply during Frid...

The following slide deck was published by Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ETCompany ParticipantsTodd Friedman -...

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California Inc (PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus estimate for Q4 2024 revenue is $40.16 millio

The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.44, representing a -1.37% change from its previous close.

**media[530945]**

Pacific Biosciences of California (PACB) closed at $1.67 in the latest trading session, marking a -1.18% move from the prior day.

Pacific Biosciences of California (PACB) closed at $2 in the latest trading session, marking a +0.5% move from the prior day.

With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.

Ark Invest sold $14.93M in Palantir shares and purchased $8.94M in Amazon stock on Monday Jan. 6, 2025, reflecting contrasting strategies amid mixed analyst sentiments.

Cathie Wood's ARK buys Intellia, sells Tesla in latest stock trades